Event Details

BioCentury Grand Rounds provides an interdisciplinary forum of top academic, investor, biotech and pharma R&D leaders that will showcase groundbreaking research, clinical insights and transformative technologies with significant commercial potential.

This conference, BioCentury’s dedicated R&D meeting, focuses on the most upstream part of the drug development continuum, the academia/industry interface.

Grand Rounds will bring together academic innovators and physician scientists with VCs and pharmas looking for breakthrough discoveries and technologies, and provide a forum to discuss critical issues in translation. A particular goal is to give investors access to innovators they do not normally meet, and likewise enable those entrepreneurs to find avenues to commercialize their discoveries.

Why Attend?

Shape the next generation of treatments: Find opportunities in groundbreaking research to build your portfolios and pipelines; meet the investors and partners who can convert your discoveries to programs and launch new companies

Connect with Industry Leaders:

Participate in panels and fireside chats with key thought leaders to explore critical translation issues and gain valuable perspectives.

Expand Your Network:

Build invaluable connections through 1:1 partnering and networking sessions, fostering collaboration with VCs, pharmas, biotechs and fellow innovators.

BioCentury’s inaugural R&D conference presents a pivotal meeting point for academic innovators, physician scientists, and industry leaders. This first-of-its-kind conference zeroes in on the academia/industry interface, spotlighting the earliest stages of discovery with significant commercial potential, fostering the conversion of groundbreaking science into impactful drug development programs, and addressing the critical bottlenecks in translational medicine.

The conference will feature:

• Poster presentations by academic innovators
• Poster and oral presentations by presenting companies
• Fireside chats with key thought leaders in industry and academia
• Panel discussions on critical topics for the translation of scientific discoveries into drug development programs
• 1:1 partnering
• Networking